ZA200308353B - Compaction process for manufacture of sodium phenytoin dosage form. - Google Patents

Compaction process for manufacture of sodium phenytoin dosage form.

Info

Publication number
ZA200308353B
ZA200308353B ZA200308353A ZA200308353A ZA200308353B ZA 200308353 B ZA200308353 B ZA 200308353B ZA 200308353 A ZA200308353 A ZA 200308353A ZA 200308353 A ZA200308353 A ZA 200308353A ZA 200308353 B ZA200308353 B ZA 200308353B
Authority
ZA
South Africa
Prior art keywords
manufacture
dosage form
compaction process
sodium phenytoin
phenytoin
Prior art date
Application number
ZA200308353A
Other languages
English (en)
Inventor
Crotts George Harland Iii
Mebrahtu Ghebretensa Fessehaie
Srinivas Raju Gadiraju
John Joseph Gawel
Isaac Ghebre-Sellassie
Ashlesh Kalyandbhai Sheth
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ZA200308353B publication Critical patent/ZA200308353B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
ZA200308353A 2001-05-15 2003-10-27 Compaction process for manufacture of sodium phenytoin dosage form. ZA200308353B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29097001P 2001-05-15 2001-05-15

Publications (1)

Publication Number Publication Date
ZA200308353B true ZA200308353B (en) 2004-07-08

Family

ID=23118256

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200308353A ZA200308353B (en) 2001-05-15 2003-10-27 Compaction process for manufacture of sodium phenytoin dosage form.

Country Status (16)

Country Link
US (1) US20030083360A1 (es)
EP (1) EP1392246A1 (es)
JP (1) JP2004531548A (es)
KR (1) KR20030096392A (es)
CN (1) CN1527700A (es)
AR (1) AR034332A1 (es)
BR (1) BR0209644A (es)
CA (1) CA2446957A1 (es)
CZ (1) CZ20033116A3 (es)
HU (1) HUP0304078A2 (es)
IL (1) IL158518A0 (es)
MX (1) MXPA03009805A (es)
PL (1) PL366728A1 (es)
RU (1) RU2262922C2 (es)
WO (1) WO2002092056A1 (es)
ZA (1) ZA200308353B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004058152A2 (en) * 2002-12-16 2004-07-15 Ranbaxy Pharmaceuticals Inc. An extended release pharmaceutical composition of phenytoin sodium
WO2004075826A2 (en) * 2003-02-28 2004-09-10 Ranbaxy Laboratories Limited Extended release, multiple unit dosage forms of phenytoin sodium and processes for their preparation
US20060034910A1 (en) * 2004-08-09 2006-02-16 Sanjay Patel Pharmaceutical composition for extended release of phenytoin sodium
HUE029572T2 (en) 2006-02-03 2017-03-28 Opko Renal Llc Treatment of Vitamin D Insufficiency and Deficiency with 25-Hydroxy-D2 and 25-Hydroxy-D3
US8329677B2 (en) 2006-06-21 2012-12-11 Cytochroma, Inc. Method of treating and preventing secondary hyperparathyroidism
FI20080348A0 (fi) * 2008-02-15 2008-05-09 Atacama Labs Oy Uudenlainen farmaseuttinen formulaatio
KR101495578B1 (ko) 2007-04-25 2015-02-25 사이토크로마 인코포레이티드 비타민 ｄ 부족 및 결핍의 치료 방법
EP3542792B1 (en) 2007-04-25 2023-06-28 EirGen Pharma Ltd. Controlled release 25-hydroxyvitamin d
US20100273873A1 (en) * 2007-07-31 2010-10-28 Katleen Rosa Francois Brys Direct compressible dextrose
CN102125522B (zh) * 2010-01-15 2013-01-16 复旦大学附属华山医院 P-糖蛋白单克隆抗体修饰的苯妥英靶向纳米制剂及其制备方法
LT2552484T (lt) 2010-03-29 2020-04-27 Opko Ireland Global Holdings, Ltd. Būdai ir kompozicijos, skirti paratiroidų lygiams sumažinti
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
CN114681468A (zh) 2014-08-07 2022-07-01 欧普科爱尔兰环球控股有限公司 利用25-羟基维生素d的辅助疗法
TW202214257A (zh) 2016-03-28 2022-04-16 愛爾蘭商歐科愛爾蘭全球控股股份有限公司 維生素d治療之方法
AU2017371467B2 (en) * 2016-12-06 2023-06-01 Jan Marius KEPPEL HESSELINK Topical phenytoin for use in the treatment of peripheral neuropathic pain
EP3551182A1 (en) 2016-12-06 2019-10-16 Topical Innovations B.V. Topical pharmaceutical composition containing phenytoin and a (co -)an algesic for the treatment of chronic pain

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274168B1 (en) * 1999-02-23 2001-08-14 Mylan Pharmaceuticals Inc. Phenytoin sodium pharmaceutical compositions

Also Published As

Publication number Publication date
PL366728A1 (en) 2005-02-07
EP1392246A1 (en) 2004-03-03
MXPA03009805A (es) 2005-03-07
CZ20033116A3 (cs) 2004-09-15
JP2004531548A (ja) 2004-10-14
KR20030096392A (ko) 2003-12-24
CA2446957A1 (en) 2002-11-21
WO2002092056A8 (en) 2003-10-23
RU2003133299A (ru) 2005-04-10
US20030083360A1 (en) 2003-05-01
WO2002092056A1 (en) 2002-11-21
RU2262922C2 (ru) 2005-10-27
CN1527700A (zh) 2004-09-08
AR034332A1 (es) 2004-02-18
HUP0304078A2 (hu) 2004-04-28
IL158518A0 (en) 2004-05-12
BR0209644A (pt) 2004-07-06

Similar Documents

Publication Publication Date Title
HUP0402063A3 (en) Indole-2-carboxamides process for producing them, pharmaceutical compositions containing them and use thereof
ZA200308353B (en) Compaction process for manufacture of sodium phenytoin dosage form.
HUP0302257A3 (en) 4-hydrazino-5-hydroxy-5-pyrazol derivatives, pharmaceutical compositions containing them, process for producing them and their intermediates
HUP0401213A3 (en) Compounds effecting glucokinase, process for their preparation and their use for production of pharmaceutical compositions
GB0117618D0 (en) Pharmaceutical dosage form
GB0117619D0 (en) Pharmaceutical dosage form
IL187126A0 (en) Process for the preparation of 4 - haloalkylnicotinonitriles
GB2381524B (en) Process for the production of xylitol
HK1039796A1 (zh) 生產過硫酸鈉的方法
IL154803A0 (en) New process for the production of oxabispidines
TWI318975B (en) Process for the production of ethers
HUP0302429A3 (en) 4-amino-quinazolines, process for producing them, pharmaceutical compositions containing them and their use
PT1446107E (pt) Composições orais de libertação controlada compreendendo um composto de vitamina d e veículo ceroso
EP1323416A4 (en) PROCESS FOR THE MANUFACTURE OF MEDICAL SOLID DISPERSIONS
MXPA02006102A (es) Metodo para preparar compuestos bormodifluoroaceticos.
HUP0202379A3 (en) New compounds, process for producing them and pharmaceutical compositions containing them
HUP0400080A3 (en) Method for the production of solid formulations of sodium 3-hydroxy-3-methylbutyrate
HUP0201024A3 (en) Izoindeindolone compounds, process for their preparation and pharmaceutical compositions containing them
AU8824201A (en) Process for the preparation of dinapsoline
IL190807A0 (en) Process for the preparation of 2-aminoethylpyridines
IL150897A0 (en) Process for the preparation of acetyl-amidiniophenylalanyl cyclohexylglycyl-pyridinioalaninamides
EP1295864A4 (en) PROCESS FOR THE PREPARATION OF 1,5-DIAMINONAPHTHALINES
MXPA03009210A (es) PROCEDIMIENTO PARA LA PREPARACIoN DE OXABISPIDINAS.
HU0100881D0 (en) New process for the preparation of isoindoline
HU0104563D0 (en) Process for producing of food-enzymes